source
- Beam Therapeutics sues YolTech and Serapha Bio over alleged theft of base editing trade secretsBeam Therapeutics has filed a lawsuit in U.S. District Court in Massachusetts accusing Chinese biotech YolTech Therapeutics and its U.S. partner Serapha Bio of using confidential information to dev…
- Novo to pay Hengrui up to $2.6 billion for rights to weekly obesity pill HRS-1596Novo announced a deal with China-based Hengrui Pharma, paying $300 million up front for rights to HRS-1596, a once‑weekly obesity pill. The agreement could rise to $2.6 billion if the candidate me…